Swiss Biotech Center

What Swiss Biotech Center does

Swiss Biotech Center is a Swiss non-profit Contract Development and Manufacturing Organization (CDMO) specializing in biopharmaceutical development and manufacturing using mammalian expression systems. The center is headquartered at the BioArk technology park in Monthey, canton of Valais, at Route de l'Ile-aux-Bois 1A, and operates in the heart of the Swiss Health Valley. Its core offering centers on producing low-bioburden active pharmaceutical ingredients ready for formulation and Fill&Finish, with a maximum batch scale of 200L fed-batch under cGMP quality standards in an ISO 7 cleanroom environment.

The underlying technology platform is built entirely on single-use systems: 50L and 200L single-use bioreactors with SCADA supervision, a Sartoflow Alpha plus SU tangential filtration system, an Akta Ready single-use chromatography unit, and Bioprofile pHOx automated chemical analyzers. This configuration is purpose-built to deliver flexibility and rapid batch turnover for clinical-stage programs rather than high-volume commercial manufacturing. The center explicitly targets early-stage biopharmaceutical innovators — start-ups, entrepreneurs, academics, and university spin-offs — and layers CDMO execution with non-manufacturing services including on-site BioArk office space, coaching by domain specialists (clinical development, regulatory affairs, quality), non-dilutive financing research support, and networking within the Swiss and international life sciences ecosystem.

The business model is professional services-based: turn-key access to biopharmaceutical development and manufacturing facilities, project-based coaching, and ancillary ecosystem services, with quote-based, project-tailored pricing. The firm generates revenue primarily through CDMO project fees and is privately held with 1–10 employees. Strategic go-to-market is anchored on direct enterprise engagement, amplified through participation in the Valais delegation at major international conferences (BIO International Convention, BIO-Europe, Swiss Biotech Days, Life Sciences Week) and partnerships with BioArk, Economic Promotion Valais, the Swiss Biotech Association, and Biotechgate Digital Partnering.

Name

Swiss Biotech Center

Legal name

Swiss Biotech Center AG

Website

https://swissbiotechcenter.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

Swiss Biotech Center is a non-profit CDMO in Monthey, Switzerland that develops and manufactures biopharmaceuticals using single-use mammalian expression systems up to 200L clinical batches under cGMP, serving early-stage start-ups, academics, and spin-offs.

Ownership category

akta.pro rank

Product category

Biopharmaceutical Contract Development and Manufacturing (CDMO)

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Biologics (mAbs/Recombinant Proteins) CDMO (HLAGABAC)

akta.pro secondary industries

Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), Drug Substance–Drug Product Integrated CDMO (HLAGABAG)

Keywords

• Biopharmaceutical contract development
• CGMP clinical manufacturing
• Mammalian cell expression
• Single-use bioreactor services
• Biotech startup incubation

Headquarters

HQ city

Monthey

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Contract Development and Manufacturing Services: Provides turn-key access to biopharmaceutical development and manufacturing facilities, including on-site office space in BioArk building, coaching by domain specialists, and support for financing research

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Swiss Biotech Center is a contract development and manufacturing organization (CDMO) that develops and produces biopharmaceutical products using mammalian expression systems, delivering low-bioburden active pharmaceutical ingredients up to cGMP-compliant clinical batches (max 200L fed-batch). It offers turnkey facility access, on-site office space, specialist coaching, financing support, and life sciences networking for entrepreneurs, start-ups, academics, and university spin-offs.

Product overview

Swiss Biotech Center is a single, unified service offering centered around biopharmaceutical development and manufacturing. Located at the BioArk technology park in Monthey, Switzerland, it provides end-to-end capabilities from mammalian expression systems to cGMP-compliant clinical batches using single-use technologies (up to 200L fed-batch). The portfolio combines core manufacturing services with supporting services including turnkey facility access, on-site office space, coaching, financing support, and networking—all designed for early-stage projects, startups, academics, and spin-offs in the life sciences sector.

Differentiator

Problem solved

Functional benefit

Products and services

• Biopharmaceutical Development and Manufacturing Contract development and manufacturing of biopharmaceutical products using mammalian expression systems up to clinical batches under cGMP quality standards, delivering bulks of low-bioburden active pharmaceutical ingredients ready for formulation and Fill&Finish. For biotech start-ups, academics, and spin-offs.
• Turnkey Facility Access Turnkey access to Swiss Biotech Center infrastructure for producing first series of products, enabling entrepreneurs, start-ups, academics, and spin-offs to develop biopharmaceutical projects.
• On-site Office Space On-site office availability in the BioArk building in Monthey for start-ups and project leaders working on biopharmaceutical development.
• Coaching and Project Follow-up Coaching and project follow-up services provided by specialists in clinical development, regulatory affairs, and quality to support the development of innovative biopharmaceutical projects.
• Financing Research Support Support services for financing research, including access to non-dilutive financing and fundraising mentorship for early-stage projects and start-ups.
• Networking and Business Development Services Networking and business development services connecting life sciences actors in Switzerland and worldwide, including industries, SMEs, research institutes, and other stakeholders, plus individualized mentoring for fundraising.

Named customers10 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Economic Promotion ValaiscoreGTM or Marketing Partner · 3 June 2024Joint participation in Valais delegation at international events including BIO US San Diego 2024 and other conferences to showcase the canton's life sciences expertise and innovations.
• BioArkcoreStrategic or Co-development PartnerBioArk is the technology park where Swiss Biotech Center is located, with sites in Monthey and Viège. BioArk is a leading technological site for life sciences in Switzerland, hosting innovative companies in the sector.
• Biotechgate Digital PartneringminorGTM or Marketing PartnerSwiss Biotech Center serves as a supporting partner of Biotechgate Digital Partnering events, offering premium registration codes to Valais life sciences players and participating in networking activities.
• Swiss Biotech AssociationcoreGTM or Marketing PartnerSwiss Biotech Center participates at the Swiss Biotech Association pavilion during events like BIO-Europe 2024, contributing to Switzerland's visibility as a leader in life sciences.
• BASFminorOthersLocated at the Monthey chemical site, one of the largest in Switzerland. Part of the dynamic life sciences ecosystem surrounding Swiss Biotech Center.
• SyngentaminorOthersLocated at the Monthey chemical site, one of the largest in Switzerland. Part of the dynamic life sciences ecosystem surrounding Swiss Biotech Center.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Cobra Biologics (Charles River Laboratories): Keele/UK-based biologics CDMO (now part of Charles River) historically focused on DNA, viral vector and mammalian-cell-derived biologics for early-stage biotech clients. Comparable on target customer and clinical-batch positioning, though bigger and more established.
• BioVian: Nordic (Finland/Turku) contract development and manufacturing organization for biopharmaceuticals, including microbial and mammalian expression, fill-finish and analytical services. Comparable as a mid-sized, founder-/startup-focused biologics CDMO operating at a similar clinical-batch scale with comparable GTM.
• ProBioGen: Berlin-based specialist CDMO for biologics, vaccines and gene therapy with CHO-based mammalian cell line expertise. Comparable to Swiss Biotech Center in serving early- and mid-stage biotech clients with mammalian-expression biologics at clinical-batch scale.
• Selexis: Switzerland-based (Geneva) cell line development specialist for the production of recombinant proteins and monoclonal antibodies. Comparable as a biologics CDMO serving early-stage biotech programs with mammalian expression technology, although focused upstream on cell-line rather than full clinical-batch manufacturing.
• ExcellGene: Monthey-based protein and monoclonal antibody production services company using mammalian expression systems. Directly comparable on technology (CHO/mammalian bioreactor-based protein production), location in BioArk, and target customer base of biotech startups; also documented as a Valais delegation partner.
• ten23 health: Visp-based Swiss biologics CDMO providing sterile fill-finish of injectables and biologics. Directly comparable on geography, customer base (early-stage biologics), and Switzerland Health Valley positioning; already a documented Valais delegation partner of Swiss Biotech Center.

Broad incumbents

• WuXi Biologics: Global biologics CDMO with extensive mammalian-cell manufacturing capacity. Comparable biologics CDMO but at vastly greater scale with global geographic reach; serves as a major competitor for early-stage work and a likely 'graduation' partner as SBC clients mature.
• AGC Biologics: Global CDMO offering mammalian and microbial biologics development and manufacturing from clinical to commercial scale. Comparable on biologics offering but materially larger and able to take clients all the way through late-stage and commercial supply.
• Lonza Biologics: World's largest mammalian-cell biologics CDMO with major Visp (Valais) and global manufacturing footprint. Comparable as biologics CDMO but operates at vastly larger commercial and clinical scales (thousands of liters) that Swiss Biotech Center cannot match.
• Merck BioReliance / MilliporeSigma CDMO Services: End-to-end biologics CDMO services within Merck KGaA's Life Science segment, providing process development through commercial-scale biologics manufacturing. Adjacent/competitor for clients graduating past Swiss Biotech Center's 200L ceiling.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/sbc_biopharma
• YouTubeyoutube.com/channel/UCyUkMUtTkdwxQs2q8KydUkg
• LinkedInlinkedin.com/company/swissbiotechcenter

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Swiss Biotech Center